Cabalquinto, Dieb A.
HRN: 07-03-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2025
CEFTRIAXONE 1G (VIAL)
01/03/2025
01/10/2025
IV
2 Grams
OD
TBI; Multiple Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & MouthCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes